COMP insider Bradley Serwin files Form 144 for stock sale

Rhea-AI Filing Summary

COMP insider Bradley Serwin filed a Form 144 notice covering a planned sale of 20,953 shares of common stock through Morgan Stanley Smith Barney on the NYSE. The filing lists an aggregate market value of $222,101.80 for these shares and notes that there were 561,061,452 shares outstanding at the time referenced. The shares to be sold were acquired as restricted stock units on 04/04/2023, with the same date shown for payment. The form also discloses recent Rule 10b5-1 sales for Serwin over the prior three months, including multiple transactions in November 2025 with stated share amounts and gross proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20953	222101.80	561061452	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/04/2023	Restricted Stock Units	Issuer			20953	04/04/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/24/2025	20952	219996.00
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/21/2025	13969	139690.00
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/12/2025	904	8588.00
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/11/2025	903	8127.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does COMPb4s latest Form 144 filing disclose?

The Form 144 filing discloses that Bradley Serwin intends to sell 20,953 shares of COMP common stock, with an aggregate market value of $222,101.80, through Morgan Stanley Smith Barney on the NYSE.

How many COMP shares are planned for sale under this Form 144?

The notice covers a proposed sale of 20,953 shares of COMP common stock, as listed in the securities information section.

What is the aggregate market value of COMP shares in this planned sale?

The aggregate market value of the 20,953 shares of COMP common stock to be sold is reported as $222,101.80.

When were the COMP shares being sold originally acquired?

The shares were acquired as restricted stock units on 04/04/2023, with the same date shown as the date of payment.

How many COMP shares were outstanding at the time referenced in the Form 144?

The filing reports 561,061,452 shares outstanding of COMP common stock in the securities information table.

What recent sales of COMP stock by Bradley Serwin are disclosed?

The filing lists Rule 10b5-1 sales for Bradley Serwin over the past three months, including sales of 20,952 shares on 11/24/2025, 13,969 shares on 11/21/2025, 904 shares on 11/12/2025, and 903 shares on 11/11/2025, each with corresponding gross proceeds.

Who is the broker for the planned COMP share sale in this Form 144?

The broker listed for the proposed sale is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.